(Q37525969)

English

Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease.

scientific article published on January 2009

Statements

Validity of cerebrospinal fluid biomarkers as endpoints in early-phase clinical trials for Alzheimer's disease (English)
0 references
0 references
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit